Judy Un Chong Ahrar, MD
Department of Interventional Radiology, Division of Diagnostic Imaging
About Dr. Ahrar
Dr. Judy Ahrar is a Professor of Interventional Radiology at UTMD Anderson Cancer Center. Dr. Ahrar received her Doctorate in Medicine from the University of Miami in 2000. Currently, Dr. Ahrar serves as the Physician Liaison for the Diagnostic Imaging Professional Quality Committee since 2007, Representative for Clinical Safety and Effectiveness Committee since 2013 and Alternative Representative for the Credentials Committee since 2013. Dr. Ahrar began her medical career at UTMD Anderson Cancer Center in 2006 as an Assistant Professor in Diagnostic Radiology and was promoted to Associate Professor in 2012. Her first experience with clinical trials was during her fellowship training at the University of Texas and reflects over 14 years of direct Clinical and Research experience with the University of Texas. Her research and clinical interests are Image guided biopsy, Lung and Mediastinum biopsy, Chemoembolization of the liver and Quality Improvement.
Read More
Present Title & Affiliation
Primary Appointment
Professor, Department of Interventional Radiology, Division of Diagnostic Imaging, Division of Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX
Assistant Professor, Department of Diagnostic and Interventional Imaging, Division of Diagnostic Imaging, The University of Texas Medical School at Houston, Houston, TX
Research Interests
Image guided biopsy, Lung and Mediastinum biopsy, Chemoembolization of the liver and Quality Improvement
Education & Training
Degree-Granting Education
| 2000 | University of Miami, Miami, Florida, US, MD |
| 1996 | University of Miami, Coral Gables, Florida, US, Biology, BS |
Postgraduate Training
| 2005-2006 | Clinical Fellowship, Interventional Radiology, The University of Texas Medical School at Houston, Houston, Texas |
| 2001-2005 | Clinical Residency, Diagnostic Radiology, The University of Texas Health Science Center, Houston, Texas |
| 2000-2001 | Clinical Internship, Internal Medicine, New Hanover Regional Medical Center, Wilmington, North Carolina |
Board Certifications
| 2023 | Advanced Cardiovascular Life Support |
| 2007 | American Board of Radiology, Interventional Radiology/Diagnostic Radiology |
| 2005 | American Board of Radiology |
Experience & Service
Academic Appointments
Associate Professor, Department of Interventional Radiology, Division of Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX, 2013 - 2018
Associate Professor, Department of Diagnostic Radiology, Division of Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX, 2012 - 2013
Assistant Professor, Department of Diagnostic Radiology, Division of Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX, 2006 - 2012
Administrative Appointments/Responsibilities
Epic Certified Physician Builder, The University of Texas MD Anderson Cancer Center, Houston, TX, 2016 - 2016
Institutional Committee Activities
Member, Specimen Source Governance Committee, 2020 - Present
Member, Perioperative Informatics Subcommittee, 2020 - Present
Member, Department of Anesthesiology Chair Search Committee, 2019 - 2020
Member, DI Informatics Functional Committee, 2015 - Present
Provider Officer, EPIC Committee, 2013 - Present
Representative, Clinical Safety and Effectiveness Committee, 2013 - Present
Representative/ Alternative, Credentials Committee, 2013 - Present
Professional Physician Liaison, Professional Quality Committee, 2007 - Present
Honors & Awards
| 2017 | Excellence in OneConnect Leadership, President's Faculty Recognition - The University of Texas MD Anderson Cancer Center |
Professional Memberships
Selected Publications
Peer-Reviewed Articles
- Pal K, Patel M, Chen SR, Odisio B, Metwalli Z, Ahrar J, Irwin D, Sheth RA, Kuban JD. A Single-center Experience with a Shear Thinning Conformable Embolic. J Vasc Interv Radiol 35(8):1215-1220, 2024. e-Pub 2024. PMID: 38719091.
- de Groot PM, Shroff GS, Ahrar J, Sabloff BS, Gladish GM, Moran C, Gupta S, Gladish GW, Chang JY, Erasmus JJ. Implications for high-precision dose radiation therapy planning or limited surgical resection after percutaneous computed tomography-guided lung nodule biopsy using a tract sealant. Adv Radiat Oncol 3(2):139-145, 2018. e-Pub 2017. PMID: 29904738.
- Litwin RJ, Huang SY, Sabir SH, Hoang QB, Ahrar K, Ahrar J, Tam AL, Mahvash A, Ensor JE, Kroll M, Gupta S. Impact of an inferior vena cava filter retrieval algorithm on filter retrieval rates in a cancer population. J Vasc Surg Venous Lymphat Disord 5(5):689-697, 2017. PMID: 28818223.
- Gupta N, Patel A, Ensor J, Ahrar K, Ahrar J, Tam A, Odisio B, Huang S, Murthy R, Mahvash A, Avritscher R, McRae S, Sabir S, Wallace M, Matin S, Gupta S. Multiple Renal Artery Pseudoaneurysms in Patients Undergoing Renal Artery Embolization Following Partial Nephrectomy: Correlation with RENAL Nephrometry Scores. Cardiovasc Intervent Radiol 40(2):202-209, 2017. e-Pub 2016. PMID: 27681271.
- Ahrar JU, Gupta S, Ensor JE, Mahvash A, Sabir SH, Steele JR, McRae SE, Avritscher R, Huang SY, Odisio BC, Murthy R, Ahrar K, Wallace MJ, Tam AL. Efficacy of a Self-expanding Tract Sealant Device in the Reduction of Pneumothorax and Chest Tube Placement Rates After Percutaneous Lung Biopsy: A Matched Controlled Study Using Propensity Score Analysis. Cardiovasc Intervent Radiol 40(2):270-276, 2017. e-Pub 2016. PMID: 27826786.
- McWilliams JP, Shah RP, Quirk M, White SB, Dybul SL, Ahrar J, Steele JR, Kwan SW, Handel J, Winokur RS, Gilliland CA, Durack JC. Standardized Reporting in IR: A Prospective Multi-Institutional Pilot Study. J Vasc Interv Radiol 27(12):1779-1785, 2016. e-Pub 2016. PMID: 27670943.
- Kuban JD, Tam AL, Huang SY, Ensor JE, Philip AS, Chen GJ, Ahrar J, Murthy R, Avritscher R, Madoff DC, Mahvash A, Ahrar K, Wallace MJ, Nachiappan AC, Gupta S. The Effect of Needle Gauge on the Risk of Pneumothorax and Chest Tube Placement After Percutaneous Computed Tomographic (CT)-Guided Lung Biopsy. Cardiovasc Intervent Radiol 38(6):1595-602, 2015. e-Pub 2015. PMID: 25920917.
- Ahrar K, Ahrar JU, Javadi S, Pan L, Milton DR, Wood CG, Matin SF, Stafford RJ. Real-time magnetic resonance imaging-guided cryoablation of small renal tumors at 1.5 T. Invest Radiol 48(6):437-44, 2013. e-Pub 2013. PMID: 23511191.
- Ahrar JU, Stafford RJ, Alzubaidi S, Ahrar K. Magnetic resonance imaging-guided biopsy in the musculoskeletal system using a cylindrical 1.5-T magnetic resonance imaging unit. Top Magn Reson Imaging 22(4):189-96, 2011. PMID: 23514926.
- Ahrar J, Gupta S, Ensor J, Ahrar K, Madoff DC, Wallace MJ, Murthy R, Tam A, Hwu P, Bedikian AY. Response, survival, and prognostic factors after hepatic arterial chemoembolization in patients with liver metastases from cutaneous melanoma. Cancer Invest 29(1):49-55, 2011. PMID: 21166498.
- Gupta S, Bedikian AY, Ahrar J, Ensor J, Ahrar K, Madoff DC, Wallace MJ, Murthy R, Tam A, Hwu P. Hepatic artery chemoembolization in patients with ocular melanoma metastatic to the liver: response, survival, and prognostic factors. Am J Clin Oncol 33(5):474-480, 2010. e-Pub 2009. PMID: 19935383.
- Ahrar K, Gowda A, Javadi S, Borne A, Fox M, McNichols R, Ahrar JU, Stephens C, Stafford RJ. Preclinical assessment of a 980-nm diode laser ablation system in a large animal tumor model. J Vasc Interv Radiol 21(4):555-561, 2010. PMID: 20346883.
- Ahrar K, Himmerich JU, Herzog CE, Raymond AK, Wallace MJ, Gupta S, Madoff DC, Morello FA, Murthy R, McRae SE, Hicks ME. Percutaneous ultrasound-guided biopsy in the definitive diagnosis of osteosarcoma. J Vasc Interv Radiol 15(11):1329-1333, 2004. PMID: 15525755.
Manuals, Teaching Aids, Other Teaching Publications
- Himmerich JU, Ahrar K. Palliation of bone and soft tissue tumors with RFA. Interventional Oncology: Current practice and future trends. Manual for Conference sponsored by the Society of Interventional Radiology, 2003.
Other Articles
- Ahrar K, Sabir SH, Yevich SM, Sheth RA, Ahrar JU, Tam AL, Stafford JR MRI-Guided Interventions in Musculoskeletal System. Top Magn Reson Imaging 27(3):129-139, 2018. PMID: 29870465.
- Javadi J, Ahrar JU, Ninan E, Gupta S, Matin S, Ahrar K Characterization of contrast enhancement in the ablation zone immediately after radiofrequency ablation of renal tumors. J Vasc Interv Radiol 21(5):690-695, 2010. PMID: 20227295.
Abstracts
- Ahrar K, Ahrar JU, Javadi S, Pan L, Milton D, Wood CG, Matin SF, Stafford RJ. Real-time MRI guided cryoablation of small renal tumors at 1.5 tesla. Global Academic Programs, 2013. PMID: None.
- Ahrar JU, Stafford RJ, Alzubaidi S, Ahrar K. MRI-guided biopsy in the musculoskeletal system using a cylindrical 1.5-T MRI unit. Global Academic Programs None(None):None, 2013. PMID: None.
- Himmerich JU, Ahrar K, Gupta S, Wallace MJ, Madoff DC, Morello FA. Intra-arterial chemotherapy for osteosarcoma: Indications, technique, and complications. Radiology 229(None):763, 2003. PMID: None.
Book Chapters
- Metwalli Z, Ahrar JU, Wallace M. Interventional Radiology for the Cancer Patient. In: Cancer Medicine. None. John Wiley & Sons, Inc, None, 2022.
- Ahrar K, Javadi S, Ahrar JU. Renal Mass Biopsy. In: Percutaneous Image-Guided Biopsy. None. Springer Science+Business Media, None, 2013.
- Ahrar JU, Ahrar K. Ultrasound-Guided Biopsy. In: Percutaneous Image-Guided Biopsy. None. Springer Science+Business Media, None, 2013.
- Ahrar JU, Javadi S, Ahrar K. Percutaneous and Transjugular Kidney Biopsy. In: Percutaneous Image-Guided Biopsy. None. Springer Science+Business Media, None, 2013.
Books (edited and written)
- Ahrar J. Cancer Medicine. Ed(s) None. None, 2015.
Grant & Contract Support
| Title: | Phase 1b, escalating dose study of AVL-292, a Bruton's Tyrosine Kimase (BtK) inhibitor, as monotherapy subjects with relapsed and/or refractory B cell Non-Hodgkin Lymphoma, chronic Lymphocytic Leukemia, and Waldenstrom's Macroglobulinemia |
| Funding Source: | Celgene Corporation |
| Role: | Collaborator |
| Title: | A phase 1b open-label, expansion study to investigate the safety, efficacy, and pharmacokinetics of intravenous CUDC-101 in subjects with advanced head and neck, gastric, breast, and liver tumors |
| Funding Source: | Curis, Inc |
| Role: | Collaborator |
| Title: | A study to determine correlation of MR thermal imaging to actual size of ablation during laser therapy of soft tissue metastases to bone |
| Funding Source: | BioTex, Inc |
| Role: | Collaborator |
| Title: | A phase I/II, open label, multi-centre study to assess the safety, tolerability, pharmacokinetics and preliminary efficacy of the Tor Kinase inhibitors AZD8055 administered orally to patients with advanced solid tumors, lymphomas and endometrial carcinoma |
| Funding Source: | AstraZeneca |
| Role: | Collaborator |
| Title: | A phase II study of SGN-30 in combination with CHOP in anaplastic large cell lymphoma |
| Funding Source: | SAIC-Frederick, Inc |
| Role: | Collaborator |
| Title: | Enhanced T-cell immunity to novel breast cancer antigens |
| Funding Source: | Susan G. Komen Breast Cancer Foundation |
| Role: | Collaborator |
Patient Reviews
CV information above last modified October 30, 2024